Aldosterone: Direct effects on and production by the heart

Journal of Clinical Endocrinology and Metabolism

Volumn 88, Issue 6, 2003, Pages 2376-2383

  White, Perrin C ^a  

^a UNIVERSITY OF TEXAS SOUTHWESTERN MEDICAL CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ACETYLCYSTEINE; ALDOSTERONE; ALDOSTERONE SYNTHASE; CYCLOSPORIN; MINERALOCORTICOID RECEPTOR; PYRROLIDINE DITHIOCARBAMATE; SPIRONOLACTONE; TACROLIMUS;

ALDOSTERONE RELEASE; AUTOCRINE EFFECT; CONGESTIVE HEART FAILURE; DNA MODIFICATION; DRUG EFFECT; GENETIC POLYMORPHISM; HEART ELECTROPHYSIOLOGY; HEART MUSCLE CELL; HEART MUSCLE FIBROSIS; HEART VENTRICLE HYPERTROPHY; HORMONE ACTION; HUMAN; INFLAMMATION; NONHUMAN; PARACRINE SIGNALING; PATHOGENESIS; PRIMARY HYPERALDOSTERONISM; PRIORITY JOURNAL; PROTEIN EXPRESSION; REVIEW; STEROIDOGENESIS; TREATMENT OUTCOME;

EID: 0038343383     PISSN: 0021972X     EISSN: None     Source Type: Journal    
DOI: 10.1210/jc.2003-030373     Document Type: Review

References (80)

1. White PC 1994 Disorders of aldosterone biosynthesis and action. N Engl J Med 331:250-258
2. Pitt B, Zannad F, Remme WJ, Cody R, Castaigne A, Perez A, Palensky J, Wittes J 1999 The effects of spironolactone on morbidity and mortality in patients with severe heart failure. N Engl J Med 341:709-717
3. Zannad F, Alla F, Dousset B, Perez A, Pitt B 2000 Limitation of excessive extracellular matrix turnover may contribute to survival benefit of spironolactone therapy in patients with congestive heart failure: insights from the randomized aldactone evaluation study (RALES). Rales Investigators. Circulation 102:2700-2706
4. Weber KT 2001 Aldosterone in congestive heart failure. N Engl J Med 345:1689-1697
5. White PC, Mune T, Agarwal AK 1997 11β-Hydroxysteroid dehydrogenase and the syndrome of apparent mineralocorticoid excess. Endocr Rev 18:135-156
6. Christ M, Douwes K, Eisen C, Bechtner G, Theisen K, Wehling M 1995 Rapid effects of aldosterone on sodium transport in vascular smooth muscle cells. Hypertension 25:117-123
7. 2+ in vascular smooth muscle cells. Circ Res 76:973-979
8. Alzamora R, Michea L, Marusic ET 2000 Role of 11β-hydroxysteroid dehydrogenase in nongenomic aldosterone effects in human arteries. Hypertension 35:1099-1104
9. Tillmann HC, Schumacher B, Yasenyev O, Junker M, Christ M, Feuring M, Wehling M 2002 Acute effects of aldosterone on intracardiac monophasic action potentials. Int J Cardiol 84:33-39
10. Lombes M, Alfaidy N, Eugene E, Lessana A, Farman N, Bonvalet JP 1995 Prerequisite for cardiac aldosterone action. Mineralocorticoid receptor and 11β-hydroxysteroid dehydrogenase in the human heart. Circulation 92:175-182
11. +-dependent 11β-hydroxysteroid dehydrogenase in the human heart. J Mol Cell Cardiol 28:781-787
12. Kayes-Wandover KM, White PC 2000 Steroidogerdc enzyme gene expression in the human heart. J Clin Endocrinol Metab 85:2519-2525
13. Young M, Fullerton MJ, Dilley R, Funder JW 1994 Mineralocorticoids, hypertension, and cardiac fibrosis. J Clin Invest 93:2578-2583
14. Brilla CG, Matsubara LS, Weber KT 1993 Anti-aldosterone treatment and the prevention of myocardial fibrosis in primary and secondary hyperaldosteronism. J Mol Cell Cardiol 25:563-575
15. Rocha R, Stier Jr CT, Kifor I, Ochoa-Maya MR, Rennke HG, Williams GH, Adler GK 2000 Aldosterone: a mediator of myocardial necrosis and renal arteriopathy. Endocrinology 141:3871-3878
16. Slight S, Ganjam VK, Nonneman DJ, Weber KT 1993 Glucocorticoid metabolism in the cardiac interstitium: 11β-hydroxysteroid dehydrogenase activity in cardiac fibroblasts. J Lab Clin Med 122:180-187
17. Kohler E, Bertschin S, Woodtli T, Resink T, Erne P 1996 Does aldosterone-induced cardiac fibrosis involve direct effects on cardiac fibroblasts? J Vasc Res 33:315-326
18. Fullerton MJ, Funder JW 1994 Aldosterone and cardiac fibrosis: in vitro studies. Cardiovasc Res 28:1863-1867
19. Zhou G, Kandala JC, Tyagi SC, Katwa LC, Weber KT 1996 Effects of angiotensin II and aldosterone on collagen gene expression and protein turnover in cardiac fibroblasts. Mol Cell Biochem 154:171-178
20. Rombouts K, Wielant A, Hellemans K, Schuppan D, Geerts A 2001 Influence of aldosterone on collagen synthesis and proliferation of rat cardiac fibroblasts. Br J Pharmacol 134:224-232
21. Stockand JD, Meszaros JG 2003 Aldosterone stimulates proliferation of cardiac fibroblasts by activating Ki-RasA and MAPK1/2 signaling. Am J Physiol 284:H176-H184
22. Slight SH, Chilakamarri VK, Nasr S, Dhalla AK, Ramires FJ, Sun Y, Ganjam VK, Weber KT 1998 Inhibition of tissue repair by spironolactone: role of mineralocorticoids in fibrous tissue formation. Mol Cell Biochem 189:47-54
23. Sun Y, Zhang J, Lu L, Chen SS, Quinn MT, Weber KT 2002 Aldosterone-induced inflammation in the rat heart: role of oxidative stress. Am J Pathol 161:1773-1781
24. Rocha R, Rudolph AE, Frierdich GE, Nachowiak DA, Kekec BK, Blomme EA, McMahon EG, Delyani JA 2002 Aldosterone induces a vascular inflammatory phenotype in the rat heart. Am J Physiol 283:H1802-H1810
25. Young MJ, Moussa L, Dilley R, Funder JW 2003 Early inflammatory responses in experimental cardiac hypertrophy and fibrosis: effects of 11β-hydroxy-steroid dehydrogenase inactivation. Endocrinology 144:1121-1125
26. Farquharson CA, Struthers AD 2002 Aldosterone induces acute endothelial dysfunction in vivo in humans: evidence for an aldosterone-induced vasculopathy. Clin Sci 103:425-431
27. Rajagopalan S, Duquaine D, King S, Pitt B, Patel P 2002 Mineralocorticoid receptor antagonism in experimental atherosclerosis. Circulation 105:2212-2216
28. Ammarguellat F, Larouche I, Schiffrin EL 2001 Myocardial fibrosis in DOCA-salt hypertensive rats: effect of endothelin ET(A) receptor antagonism. Circulation 103:319-324
29. Ammarguellat FZ, Gannon PO, Amiri F, Schiffrin EL 2002 Fibrosis, matrix metalloproteinases, and inflammation in the heart of DOCA-salt hypertensive rats: role of ET(A) receptors. Hypertension 39:t-84
30. 2+ current in adult rat cardiomyocytes. Circ Res 85:1139-1145
31. Molkentin JD, Lu JR, Antos CL, Markham B, Richardson J, Robbins J, Grant SR, Olson EN 1998 A calcineurin-dependent transcriptional pathway for cardiac hypertrophy. Cell 93:215-228
32. Takeda Y, Yoneda T, Demura M, Usukura M, Mabuchi H 2002 Calcineurin inhibition attenuates mineralocorticoid-induced cardiac hypertrophy. Circulation 105:677-679
33. Wang J, Yu L, Solenberg PJ, Gelbert L, Geringer CD, Steinberg MI 2002 Aldosterone stimulates angiotensin-converting enzyme expression and activity in rat neonatal cardiac myocytes. J Card Fail 8:167-174
34. Robert V, Heymes C, Silvestre JS, Sabri A, Swynghedauw B, Delcayre C 1999 Angiotensin AT1 receptor subtype as a cardiac target of aldosterone: role in aldosterone-salt-induced fibrosis. Hypertension 33:981-986
35. Molkentin JD, GW 2001 Cytoplasmic signaling pathways that regulate cardiac hypertrophy. Annu Rev Physiol 63:391-426
36. Sheppard KE, Autelitano DJ 2002 11β-Hydroxysteroid dehydrogenase 1 transforms 11-dehydrocorticosterone into transcriptionally active glucocorticoid in neonatal rat heart. Endocrinology 143:198-204
37. + pump. Circ Res 86:37-42
38. Lim PO, Farquharson CA, Shiels P, Jung RT, Struthers AD, MacDonald TM 2001 Adverse cardiac effects of salt with fludrocortisone in hypertension. Hypertension 37:856-861
39. Caballero R, Moreno I, Gonzalez T, Arias C, Valenzuela C, Delpon E, Tamargo J 2003 Spironolactone and its main metabolite, canrenoic acid, block human ether-a-go-go-related gene channels. Circulation 107:889-895
40. Wehling M, Spes CH, Win N, Janson CP, Schmidt BM, Theisen K, Christ M 1998 Rapid cardiovascular action of aldosterone in man. J Clin Endocrinol Metab 83:3517-3522
41. le Menuet D, Isnard R, Bichara M, Viengchareun S, Muffat-Joly M, Walker F, Zennaro MC, Lombes M 2001 Alteration of cardiac and renal functions in transgerdc mice overexpressing human mineralocorticoid receptor. J Biol Chem 276:38911-38920
42. Hubert C, Gasc JM, Berger S, Schutz G, Corvol P 1999 Effects of mineralocorticoid receptor gene disruption on the components of the renin-angiotensin system in 8-day-old mice. Mol Endocrinol 13:297-306
43. Beggah AT, Escoubet B, Puttini S, Cailmail S, Delage V, Ouvrard-Pascaud A, Bocchi B, Peuchmaur M, Delcayre C, Farman N, Jaisser F 2002 Reversible cardiac fibrosis and heart failure induced by conditional expression of an antisense mRNA of the mineralocorticoid receptor in cardiomyocytes. Proc Natl Acad Sci USA 99:7160-7165
44. Young MJ, Clyne CD, Cole TJ, Funder JW 2001 Cardiac steroidogenesis in the normal and failing heart. J Clin Endocrinol Metab 86:5121-5126
45. Silvestre JS, Robert V, Heymes C, Aupetit-Faisant B, Mouas C, Moalic JM, Swynghedauw B, Delcayre C 1998 Myocardial production of aldosterone and corticosterone in the rat. Physiological regulation. J Biol Chem 273:4883-4891
46. Takeda Y, Yoneda T, Demura M, Miyamori I, Mabuchi H 2000 Cardiac aldosterone production in genetically hypertensive rats. Hypertension 36:495-500
47. Takeda Y, Yoneda T, Demura M, Miyamori I, Mabuchi H 2000 Sodium-induced cardiac aldosterone synthesis causes cardiac hypertrophy. Endocrinology 141:1901-1904
48. Takeda Y, Yoneda T, Demura M, Furukawa K, Miyamori I, Mabuchi H 2001 Effects of high sodium intake on cardiovascular aldosterone synthesis in stroke-prone spontaneously hypertensive rats. J Hypertens 19:t-9
49. Ito T, Yoshimura M, Nakamura S, Nakayama M, Shimasaki Y, Harada E, Mizuno Y, Yamamuro M, Harada M, Saito Y, Nakao K, Kurihara H, Yasue H, Ogawa H 2003 Inhibitory effect of natriuretic peptides on aldosterone synthase gene expression in cultured neonatal rat cardiocytes. Circulation 107:807-810
50. Satoh M, Nakamura M, Saitoh H, Satoh H, Akatsu T, Iwasaka J, Masuda T, Hiramori K 2002 Aldosterone synthase (CYP11B2) expression and myocardial fibrosis in the failing human heart. Clin Sci 102:381-386
51. Yoshimura M, Nakamura S, Ito T, Nakayama M, Harada E, Mizuno Y, Sakamoto T, Yamamuro M, Saito Y, Nakao K, Yasue H, Ogawa H 2002 Expression of aldosterone synthase gene in failing human heart: quantitative analysis using modified real-time polymerase chain reaction. J Clin Endocrinol Metab 87:3936-3940
52. Mizuno Y, Yoshimura M, Yasue H, Sakamoto T, Ogawa H, Kugiyama K, Harada E, Nakayama M, Nakamura S, Ito T, Shimasaki Y, Saito Y, Nakao K 2001 Aldosterone production is activated in failing ventricle in humans. Circulation 103:72-77
53. Delcayre C, Swynghedauw B 2002 Molecular mechanisms of myocardial remodeling The role of aldosterone. J Mol Cell Cardiol 34:1577-1584
54. Silvestre JS, Heymes C, Oubenaissa A, Robert V, Aupetit-Faisant B, Carayon A, Swynghedauw B, Delcayre C 1999 Activation of cardiac aldosterone production in rat myocardial infarction: effect of angiotensin II receptor blockade and role in cardiac fibrosis. Circulation 99:2694-2701
55. Xiu JC, Wu P, Xu JP, Guo Z, Lai W, Zhang Y, Li S, Li J, Liu Y 2002 Effects of long-term enalapril and losartan therapy of heart failure on cardiovascular aldosterone. J Endocrinol Invest 25:463-468
56. Hanawa H, Abe S, Hayashi M, Yoshida T, Yoshida K, Shiono T, Fuse K, Ito M, Tachikawa H, Kashimura T, Okura Y, Kato K, Kodama M, Maruyama S, Yamamoto T, Aizawa Y 2002 Time course of gene expression in rat experimental autoimmune myocarditis. Clin Sci 103:623-632
57. Tsutamoto T, Wada A, Maeda K, Mabuchi N, Hayashi M, Tsutsui T, Ohnishi M, Sawaki M, Fujii M, Matsumoto T, Horie H, Sugimoto Y, Kinoshita M 2000 Spironolactone inhibits the transcardiac extraction of aldosterone in patients with congestive heart failure. J Am Coll Cardiol 36:838-844
58. Gomez-Sanchez CE, Foecking MF, Gomez-Sanchez EP 2001 Aldosterone esters and the heart. Am J Hypertens 14:S200-S205
59. Funder JW, Pearce PT, Smith R, Campbell J 1989 Vascular type I aldosterone binding sites are physiological mineralocorticoid receptors. Endocrinology 125:2224-2226
60. Lombes M, Oblin ME, Gasc JM, Baulieu EE, Farman N, Bonvalet JP 1992 Immunohistochemical and biochemical evidence for a cardiovascular mineralocorticoid receptor. Circ Res 71:503-510
61. Kornel L 1994 Colocalization of 11 beta-hydroxysteroid dehydrogenase and mineralocorticoid receptors in cultured vascular smooth muscle cells. Am J Hypertens 7:100-103
62. Hatakeyama H, Miyamori I, Fujita T, Takeda Y, Takeda R, Yamamoto H 1994 Vascular aldosterone. Biosynthesis and a link to angiotensin II-induced hypertrophy of vascular smooth muscle cells. J Biol Chem 269:24316-24320
63. Moura AM, Worcel M 1984 Direct action of aldosterone on transmembrane 22Na efflux from arterial smooth muscle. Rapid and delayed effects. Hypertension 6:425-430
64. Takeda Y, Miyamori I, Yoneda M, Hatakeyama H, Inaba S, Furukawa K, Mabuchi H, Takeda R 1996 Regulation of aldosterone synthase in human vascular endothelial cells by angiotensin II and adrenocorticotropin. J Clin Endocrinol Metab 81:2797-2800
65. Takeda Y, Miyamori I, Yoneda T, Iki K, Hatakeyama H, Takeda R 1994 Gene expression of 11β-hydroxysteroid dehydrogenase in the mesenteric arteries of genetically hypertensive rats. Hypertension 23:577-580
66. Takeda Y, Miyamori I, Yoneda T, Iki K, Hatakeyama H, Blair IA, Hsieh, FY, Takeda R 1995 Production of aldosterone in isolated rat blood vessels. Hypertension 25:170-173
67. White PC, Slutsker L 1995 Haplotype analysis of CYP11B2. Endocr Res 21:437-442
68. Bassett MH, Zhang Y, Clyne C, White PC, Rainey WE 2002 Differential regulation of aldosterone synthase and 11β-hydroxylase transcription by steroidogenic factor-1. J Mol Endocrinol 28:125-135
69. Clyne CD, Zhang Y, Slutsker L, Mathis JM, White PC, Rainey WE 1997 Angiotensin II and potassium regulate human CYP11B2 transcription through common cis elements. Mol Endocrinol 11:638-649
70. Hautanen A, Lankinen L, Kupari M, Janne OA, Adlercreutz H, Nikkila H, White PC 1998 Associations between aldosterone synthase gene polymorphism and the adrenocortical function in males. J Intern Med 244:11-18
71. Pojoga L, Gautier S, Blanc H, Guyene TT, Poirier O, Cambien F, Benetos A 1998 Genetic determination of plasma aldosterone levels in essential hypertension. Am J Hypertens 11:856-860
72. Kupari M, Hautanen A, Lankinen L, Koskinen P, Virolainen J, Nikkila H, White PC 1998 Associations between human aldosterone synthase (CYP11B2) gene polymorphisms and left ventricular size, mass and function. Circulation 97:569-575
73. Brand E, Chatelain N, Mulatero P, Fery I, Curnow KM, Jeunemaitre X, Corvol P, Pascoe L, Soubrier F 1998 Structural analysis and evaluation of the aldosterone synthase gene in hypertension. Hypertension 32:198-204
74. Davies E, Holloway CD, Ingram MC, Inglis GC, Friel EC, Morrison C, Anderson NH, Fraser R, Connell JM 1999 Aldosterone excretion rate and blood pressure in essential hypertension are related to polymorphic differences in the aldosterone synthase gene CYP11B2. Hypertension 33:703-707
75. Lim PO, MacDonald TM, Holloway C, Friel E, Anderson NH, Dow E, Jung RT, Davies E, Fraser R, Connell JM 2002 Variation at the aldosterone synthase (CYP11B2) locus contributes to hypertension in subjects with a raised aldosterone-to-renin ratio. J Clin Endocrinol Metab 87:4398-4402
76. Delles C, Erdmann J, Jacobi J, Hilgers KF, Fleck E, Regitz-Zagrosek V, Schmieder RE 2001 Aldosterone synthase (CYP11B2) - 344 C/T polymorphism is associated with left ventricular structure in human arterial hypertension. J Am Coll Cardiol 37:878-884
77. Ylitalo A, Airaksinen KEJ, Hautanen A, Kupari M, Carson M, Virolainen J, Savolainen MJ, Kauma H, Kesaniemi A, White PC, Huikari H, Baroreflex sensitivity and variants of the renin angiotensin system genes. J Am Coll Cardiol 35:194-200
78. Hautanen A, Toivanen P, Manttari M, Tenkanen L, Kupari M, Manninen V, Kayes KM, Rosenfeld S, White PC 1999 Joint effects of an aldosterone synthase (CYP11B2) gene polymorphism and classic risk factors on risk of myocardial infarction. Circulation 100:2213-2218
79. Schunkert H, Hengstenberg C, Holmer SR, Broeckel U, Luchner A, Muscholl MW, Kurzinger S, Doring A, Hense HW, Riegger GA 1999 Lack of association between a polymorphism of the aldosterone synthase gene and left ventricular structure. Circulation 99:2255-2260
80. Hengstenberg C, Holmer SR, Mayer B, Lowel H, Engel S, Hense HW, Riegger GA, Schunkert H 2000 Evaluation of the aldosterone synthase (CYP11B2) gene polymorphism in patients with myocardial infarction. Hypertension 35:704-709